Thomson Reuters' Intellectual Property & Science division has launched a new mobile oncology decision support solution to support R&D focused pharmaceutical majors. The solution provides a series of oncology-based clinical dashboards that ...
Tags: Thomson Reuters, new mobile oncology decision support solution
Xybion's Pristima Preclinical Software suite has been selected for early-stage drug discovery pathology data management by a top-5 biotech firm. Pristima suite is the fully integrated preclinical and vivarium management solution that ...
PAREXEL International has introduced PAREXEL MyTrials platform to provide support for the drug development process. Perceptive Informatics, PAREXEL's technology subsidiary, developed the fully-integrated eClinical platform. PAREXEL ...
Sygnis Pharma will join forces with X-Pol Biotech to secure sustainable business model. The company believes that the changes are essential after the termination of clinical development activities in December 2011. Sygnis' new business ...
Merck Serono, a division of Merck, and Auxogyn have partnered to develop Early Embryo Viability Assessment (Eeva) test. Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of ...
Tags: Early Embryo Viability Assessment test, eeva test, clinical development
CeeTox and Cellular Dynamics International (CDI) have introduced a new predictive cardiac safety screening service, Cardiac Arrhythmia Assessment Screen (CAAS), which uses human induced pluripotent stem (iPS) cell-derived cardiomyocytes. ...
TNI BioTech and Hubei Qianjiang Pharmaceutical have entered into a partnership to develop new cancer therapeutics. The cancer drugs will be based on TNI BioTech's patents covering Methionine Enkephalin. TNI BioTech will carry out ...
Tags: Hubei Qianjiang Pharmaceutical, cancer drugs, methionine enkephalin
Nextrials has partnered with InClin to deliver next generation clinical research services. As part of the partnership, researchers are expected to have the advantage of linking Nextrials' Prism, a clinical trial data management ...
Tags: clinical research services, company cooperation, clinical plaform
PharmaInformatic has developed a comprehensive database on bioavailability to develop targeted new drugs. The new knowledge base, called PACT-F (Preclinical And Clinical Trials Knowledge Base on Bioavailability) combines the results ...
German-based Evotec has partnered with Probiodrug to advance the development operations of drugs targeting major age related diseases such as Alzheimer's disease(AD). Evotec will support the pre-clinical and clinical development of ...
Tags: Alzheimer's disease, Evotec, glutaminyl cyclase, neurodegeneration
Sweden based Karolinska Institutet and Immunomedics scientists have collaborated to design and test new class of drugs that destroy the AIDS virus, HIV (Human Immunodeficiency Virus), which may also help in eliminating the virus completely. ...
Tags: Immunomedics, anti-HIV agents, virus
Cellectis stem cells, a business unit of Cellectis Group, has introduced hiPS-HEP, a human iPS derived hepatocyte product. The hiPS-HEP, with homogeneity, a long life span of stable CYP activity and reproducibility, provides a range of in ...
Tags: hiPS-HEP, iPS derived hepatocyte product, vitro applications
Curis, a drug development company, has reported a net loss of $3.38m, or $0.04 per share, for the third quarter ended 30 September 2012 compared to a net loss of $4.21m, or $0.05 per share, for the third quarter ended 30 September 2011. ...
Tags: Net Loss, proprietary and licensed programs, clinical trial
The University of Washington (UW), University of Texas Medical Branch (UTMB) at Galveston, US, and Kineta have been granted a $8.1m biodefense award by the National Institute of Allergy and Infectious Diseases (NIAID). The funding aims to ...
Tags: the National Institute of Allergy and Infectious Diseases
Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...
Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug